Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF

Authors :: Francesco Lanza
J. F. Apperley
Rafael F. Duarte
Kai Hübel
K. Douglas
Wieslaw Wiktor-Jedrzejczak
Ozren Jakšić
Catarina Geraldes
Zdenek Koristek
Gabor Mikala
Nina Worel
Mohamad Mohty
Ian H Gabriel
Roberto M. Lemoli
Grzegorz W. Basak
Dominik Selleslag
Basak G.W.
Wiktor Jedrzejczak W.
Apperley J.F.
Douglas K.W.
Gabriel I.H.
Geraldes C.
Hübel K.
Jaksic O.
Koristek Z.
Lanza F.
Lemoli R.
Mikala G.
Selleslag D.
Worel N.
Mohty M.
Duarte R.F.
Source :: Bone marrow transplantation. 47(7)
Publication Year :: 2011
Abstract: Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF.

Subjects :: Oncology
Male
Benzylamines
Lymphoma
Stem cell mobilization
Cyclams
Body Mass Index
0302 clinical medicine
Adult
Aged
Aged, 80 and over
Contraindications
Female
Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cell Mobilization
Heterocyclic Compounds
Hodgkin Disease
Humans
Lymphoma, Non-Hodgkin
Middle Aged
Multiple Myeloma
Obesity
Overweight
Retrospective Studies
Thinness
Young Adult
80 and over
Young adult
Hematology
3. Good health
Granulocyte colony-stimulating factor
030220 oncology & carcinogenesis
medicine.drug
medicine.medical_specialty
Motility
Non-Hodgkin
G-CSF
NO
03 medical and health sciences
BMI
Internal medicine
medicine
Transplantation
business.industry
Plerixafor
Stem Cell Mobilization
nutritional and metabolic diseases
Retrospective cohort study
medicine.disease
Immunology
business
Body mass index
030215 immunology

Tools